| Year |
Citation |
Score |
| 2020 |
Drake LR, Brooks AF, Stauff J, Sherman PS, Arteaga J, Koeppe RA, Reed A, Montavon TJ, Skaddan MB, Scott PJH. Strategies for PET imaging of the receptor for advanced glycation endproducts (RAGE). Journal of Pharmaceutical Analysis. 10: 452-465. PMID 33133729 DOI: 10.1016/J.Jpha.2020.07.009 |
0.372 |
|
| 2019 |
Skaddan MB, Wüst FR, Katzenellenbogen JA. Synthesis and Binding Affinities of Novel Re-Containing 7alpha-Substituted Estradiol Complexes: Models for Breast Cancer Imaging Agents. The Journal of Organic Chemistry. 64: 8108-8121. PMID 11674724 DOI: 10.1021/Jo990641G |
0.459 |
|
| 2017 |
Zhang L, Chen L, Beck EM, Chappie TA, Coelho RV, Doran SD, Fan KH, Humphrey JM, Hughes Z, Kuszpit K, Lachapelle EA, Lazzaro JT, Mather RJ, Patel NC, Skaddan MB, et al. The Discovery of a Novel Phosphodiesterase (PDE) 4B-preferring Radioligand for Positron Emission Tomography (PET) Imaging. Journal of Medicinal Chemistry. PMID 28957634 DOI: 10.1021/acs.jmedchem.7b01050 |
0.301 |
|
| 2016 |
Chen L, Nabulsi N, Naganawa M, Zasadny K, Skaddan MB, Zhang L, Najafzadeh S, Lin SF, Helal CJ, Boyden TL, Chang C, Ropchan J, Carson RE, Villalobos A, Huang Y. Preclinical Evaluation of 18F-PF-05270430, a Novel PET Radioligand for the Phosphodiesterase 2A Enzyme. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 27199356 DOI: 10.2967/Jnumed.115.171454 |
0.51 |
|
| 2013 |
Zhang L, Villalobos A, Beck EM, Bocan T, Chappie TA, Chen L, Grimwood S, Heck SD, Helal CJ, Hou X, Humphrey JM, Lu J, Skaddan MB, McCarthy TJ, Verhoest PR, et al. Design and selection parameters to accelerate the discovery of novel central nervous system positron emission tomography (PET) ligands and their application in the development of a novel phosphodiesterase 2A PET ligand. Journal of Medicinal Chemistry. 56: 4568-79. PMID 23651455 DOI: 10.1021/jm400312y |
0.336 |
|
| 2012 |
Skaddan MB, Zhang L, Johnson DS, Zhu A, Zasadny KR, Coelho RV, Kuszpit K, Currier G, Fan KH, Beck EM, Chen L, Drozda SE, Balan G, Niphakis M, Cravatt BF, et al. The synthesis and in vivo evaluation of [18F]PF-9811: a novel PET ligand for imaging brain fatty acid amide hydrolase (FAAH). Nuclear Medicine and Biology. 39: 1058-67. PMID 22571907 DOI: 10.1016/J.Nucmedbio.2012.03.011 |
0.341 |
|
| 2011 |
Singhal T, Ding YS, Weinzimmer D, Normandin MD, Labaree D, Ropchan J, Nabulsi N, Lin SF, Skaddan MB, Soeller WC, Huang Y, Carson RE, Treadway JL, Cline GW. Pancreatic beta cell mass PET imaging and quantification with [11C]DTBZ and [18F]FP-(+)-DTBZ in rodent models of diabetes. Molecular Imaging and Biology : Mib : the Official Publication of the Academy of Molecular Imaging. 13: 973-84. PMID 20824509 DOI: 10.1007/S11307-010-0406-X |
0.504 |
|
| 2011 |
Comery T, Zasadny K, Morris E, Antinew J, Bell J, Billing B, Boyden T, Esterlis I, Huang Y, Kupiec J, Kuszpit K, Leil T, Nabulsi N, Planeta-Wilson B, Plotka A, ... Skaddan M, et al. Receptor occupancy of the 5-HT6 receptor antagonist SAM-760 in non-human primates and healthy human volunteers Alzheimers & Dementia. 7. DOI: 10.1016/J.Jalz.2011.05.2278 |
0.486 |
|
| 2002 |
Skaddan MB, Jewett DM, Sherman PS, Kilbourn MR. (R)-N-[11C]methyl-3-pyrrolidyl benzilate, a high-affinity reversible radioligand for PET studies of the muscarinic acetylcholine receptor Synapse. 45: 31-37. PMID 12112411 DOI: 10.1002/Syn.10079 |
0.579 |
|
| 2001 |
Skaddan MB, Sherman PS, Kilbourn MR. The role of species-dependent metabolism in the regional brain retention of 18F-labeled muscarinic acetylcholine receptor ligands Nuclear Medicine and Biology. 28: 753-759. PMID 11578895 DOI: 10.1016/S0969-8051(01)00240-2 |
0.567 |
|
| 2001 |
Skaddan MB, Kilbourn MR, Snyder SE, Sherman PS. Acetylcholinesterase inhibition increases in vivo N-(2-[18F]fluoroethyl)-4-piperidyl benzilate binding to muscarinic acetylcholine receptors Journal of Cerebral Blood Flow and Metabolism. 21: 144-148. PMID 11176279 DOI: 10.1097/00004647-200102000-00005 |
0.559 |
|
| 2001 |
Snyder SE, Gunupudi N, Sherman PS, Butch ER, Skaddan MB, Kilbourn MR, Koeppe RA, Kuhl DE. Radiolabeled cholinesterase substrates: in vitro methods for determining structure-activity relationships and identification of a positron emission tomography radiopharmaceutical for in vivo measurement of butyrylcholinesterase activity. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 21: 132-43. PMID 11176278 DOI: 10.1097/00004647-200102000-00004 |
0.487 |
|
| 2001 |
Skaddan MB, Jewett DM, Kilbourn MR, Sherman PS. The synthesis, 11C-labeling, and biological evaluation of (R)-N-[11C]methyl-3-pyrrolidyl benzilate as an acetylcholine-sensitive ligand for the muscarinic acetylcholine receptor Journal of Labelled Compounds and Radiopharmaceuticals. 44: S24-S25. DOI: 10.1002/Jlcr.2580440109 |
0.547 |
|
| 2000 |
Skaddan MB, Kilbourn MR, Snyder SE, Sherman PS, Desmond TJ, Frey KA. Synthesis, 18F-labeling, and biological evaluation of piperidyl and pyrrolidyl benzilates as in vivo ligands for muscarinic acetylcholine receptors Journal of Medicinal Chemistry. 43: 4552-4562. PMID 11087580 DOI: 10.1021/Jm000305O |
0.57 |
|
| 2000 |
Skaddan MB, Wüst FR, Jonson S, Syhre R, Welch MJ, Spies H, Katzenellenbogen JA. Radiochemical synthesis and tissue distribution of Tc-99m-labeled 7alpha-substituted estradiol complexes. Nuclear Medicine and Biology. 27: 269-78. PMID 10832084 DOI: 10.1016/S0969-8051(00)00083-4 |
0.425 |
|
| 1999 |
Wüst F, Skaddan MB, Leibnitz P, Spies H, Katzenellenbogen JA, Johannsen B. Synthesis of novel progestin-rhenium conjugates as potential ligands for the progesterone receptor Bioorganic and Medicinal Chemistry. 7: 1827-1835. PMID 10530930 DOI: 10.1016/S0968-0896(99)00119-4 |
0.492 |
|
| 1999 |
Skaddan MB, Katzenellenbogen JA. Integrated "3+1" oxorhenium(V) complexes as estrogen mimics. Bioconjugate Chemistry. 10: 119-29. PMID 9893973 DOI: 10.1021/Bc980094Q |
0.445 |
|
| Show low-probability matches. |